All these findings demonstrate that IL-6 inducing ATM activation increases the expression of MMP-3/MMP-13, augments the abilities of cell migration and promotes lung cancer metastasis, indicating that ATM is a potential target molecule to overcome IL-6 correlated lung cancer metastasis. Here, MMP3 is linked to lung carcinoma.